Why Ariad Pharmaceuticals Rocketed More Than 40% Higher Today
Baxalta is trying to buy Ariad Pharmaceuticals, but a deal hasn't been finalized.
A Reduced Payout Could Be in the Cards for These High-Yield Dividend Stocks
GlaxoSmithKline and PDL BioPharma offer investors sector-crushing yields at current levels. But there's good reason to believe they won't last much longer.